Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia

Brain : a Journal of Neurology
O RascolF Chollet

Abstract

We have studied the regional cerebral blood flow (rCBF) changes induced by the execution of a finger-to-thumb opposition motor task in the supplementary and primary motor cortex of two groups of parkinsonian patients on L-dopa medication, the first one without L-dopa induced dyskinesia (n = 23) and the other with moderate peak-dose dyskinesia (n = 15), and of a group of 14 normal subjects. Single photon emission tomography with i.v. 133Xe was used to measure the rCBF changes. The dyskinetic parkinsonian patients exhibited a pattern of response which was markedly different from those of the normal subjects and non-dyskinetic parkinsonian patients, with a significant overactivation in the supplementary motor area and the ipsi- and contralateral primary motor areas. These results are compatible with the hypothesis that an hyperkinetic abnormal involuntary movement, like L-dopa-induced peak dose dyskinesia, is due to a disinhibition of the primary and associated motor cortex secondary to an excessive outflow of the pallidothalamocortical motor loop.

Citations

Mar 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·F DurifY Agid
Sep 1, 2006·Experimental Brain Research·Sarah LemieuxChristian Duval
Apr 9, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Allan D WuAlvaro Pascual-Leone
Oct 14, 2003·Experimental Neurology·Brian HenryJonathan M Brotchie
Aug 5, 2003·Experimental Neurology·C ChassainF Durif
Apr 12, 2003·Trends in Neurosciences·Erwan BezardJonathan M Brotchie
Jan 31, 2002·Neurophysiologie clinique = Clinical neurophysiology·S ThoboisE Broussolle
Aug 22, 2001·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·T HashimotoN Yanagisawa
Oct 29, 2000·Trends in Neurosciences·D J Brooks
Oct 5, 2007·Nature Clinical Practice. Neurology·Diego CentonzeGiacomo Koch
Aug 27, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael P Caligiuri, Casey Buitenhuys
Feb 9, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marina DelfinoOscar S Gershanik
Nov 10, 2010·Brain : a Journal of Neurology·Maria C Rodriguez-OrozJose A Obeso
Jan 22, 2002·Clinical Neuropharmacology·O Rascol, N Fabre
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Martin NiethammerDavid Eidelberg
Apr 10, 2009·The Journal of Pharmacology and Experimental Therapeutics·Daniella RylanderM Angela Cenci
Dec 6, 2012·Neurology Research International·Marisa De RoseAngelo Lavano
Aug 1, 2010·Continuum : Lifelong Learning in Neurology·Anjan Chatterjee, H Branch Coslett
Apr 3, 2008·Neurosurgery·Jorge GuridiMiguel Manrique
Oct 24, 2014·Neuroreport·Tanja C W NijboerJohanna M A Visser-Meily
Oct 31, 2013·Journal of Neurotrauma·Patrice PéranRita Formisano
Dec 3, 2009·Expert Review of Neurotherapeutics·Jean-Pascal Lefaucheur
Feb 11, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Viviana PonzoGiacomo Koch
Jul 29, 2015·Neuroscience and Biobehavioral Reviews·Haritz Jiménez-UrbietaMaría C Rodriguez-Oroz
Aug 15, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Antonio CerasaAldo Quattrone
Dec 14, 2011·Behavioural Brain Research·Lorenza S ColzatoS A Wylie
Aug 3, 2010·Neurophysiologie clinique = Clinical neurophysiology·F VacherotJ-P Azulay
Oct 27, 2009·Journal of the Neurological Sciences·Ryuichi TakahashiYo Nishimura
Sep 11, 2008·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Pierre PayouxPhilippe Damier
Apr 3, 2007·Trends in Neurosciences·M Angela Cenci
Feb 17, 2007·Lancet Neurology·Alberto Priori, Jean-Pascal Lefaucheur

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.